TY - JOUR
T1 - Results of BCG adjuvant immunotherapy for melanoma of the head and neck
AU - Eilber, Frederick R.
AU - Townsend, Courtney M.
AU - Morton, Donald L.
PY - 1976/10
Y1 - 1976/10
N2 - The present study was performed to determine if postoperative systemic BCG adjuvant immunotherapy would improve survival in patients with pathologic stage II melanoma of the head and neck. Seventeen of twenty-five (68 per cent) patients treated with BCG are free of disease, whereas only seven of seventeen (40 per cent) patients treated by radical neck dissection alone are free of disease. Clark's technic for determining the level of invasion of the primary lesion was used to predict the presence of metastatic tumor in regional lymph nodes. Results indicate that patients with pathologically confirmed lymph node metastases from melanoma of the head and neck benefit from postoperative BCG adjuvant immunotherapy.
AB - The present study was performed to determine if postoperative systemic BCG adjuvant immunotherapy would improve survival in patients with pathologic stage II melanoma of the head and neck. Seventeen of twenty-five (68 per cent) patients treated with BCG are free of disease, whereas only seven of seventeen (40 per cent) patients treated by radical neck dissection alone are free of disease. Clark's technic for determining the level of invasion of the primary lesion was used to predict the presence of metastatic tumor in regional lymph nodes. Results indicate that patients with pathologically confirmed lymph node metastases from melanoma of the head and neck benefit from postoperative BCG adjuvant immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0017141485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017141485&partnerID=8YFLogxK
U2 - 10.1016/0002-9610(76)90323-8
DO - 10.1016/0002-9610(76)90323-8
M3 - Article
C2 - 1015538
AN - SCOPUS:0017141485
SN - 0002-9610
VL - 132
SP - 476
EP - 479
JO - The American Journal of Surgery
JF - The American Journal of Surgery
IS - 4
ER -